Hepatitis C elimination: Sustaining the Canadian response during and after COVID-19
The Blueprint to Inform Hepatitis C Elimination Efforts in Canada was released a year ago as a road map to guide the response to hepatitis C in Canada. However, the novel coronavirus disease (COVID-19) pandemic has had a major impact on hepatitis C services and has put certain populations at greater risk of infection. Despite this, Canada has committed to reach elimination by 2030. In order to sustain our efforts during and after COVID-19, there may be opportunities to adapt and streamline services and consider new models of care.
In this webinar, leading voices in hepatitis C will explore the implications of COVID-19 for elimination efforts and for people living with hepatitis C, and how to address these issues and the pathway to elimination during and after the pandemic.
Moderator: Christopher Hoy, Knowledge Specialist, Hepatitis C Community Health Programming, CATIE
- Dr. Jordan Feld, Clinician Scientist, University Health Network
- Jason Altenberg, Chief Executive Officer, South Riverdale Community Health Centre
- Mary Guyton, nurse, Toronto Community Hep C Program, Canadian Association of Hepatology Nurses
- Carrielynn Lund, DRUM & SASH/CanHepC Coordinator, Canadian Aboriginal AIDS Network
- Dr. Naveed Janjua, Epidemiologist and Senior Scientist, B.C. Centre for Disease Control
- Doug Belanger, Community Support Worker, Toronto Community Hep C Program
Une version française de ce webinaire sera prévu sous peu. Afin d’être averti de celui-ci, abonnez-vous aux Nouvelles liées aux webinaires